The Optimal Treatment for Stage IIIA-N2 Non-small-cell Lung Cancer: A Network Meta-analysis

Background. The optimal treatment for stage IIIA-N2 non-small cell lung cancer (NSCLC) is controversial. We aimed to address this important issue through a Bayesian network meta-analysis. Methods. We performed a search of electronic databases for randomized controlled trials comparing the following treatments: surgery, radiotherapy, chemo...More